BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36421696)

  • 1. Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial.
    Seshima F; Bizenjima T; Aoki H; Imamura K; Kita D; Irokawa D; Matsugami D; Kitamura Y; Yamashita K; Sugito H; Tomita S; Saito A
    Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodontal surgery using rhFGF-2 with deproteinized bovine bone mineral or rhFGF-2 alone: 2-year follow-up of a randomized controlled trial.
    Aoki H; Bizenjima T; Seshima F; Sato M; Irokawa D; Yoshikawa K; Yoshida W; Imamura K; Matsugami D; Kitamura Y; Kita D; Sugito H; Tomita S; Saito A
    J Clin Periodontol; 2021 Jan; 48(1):91-99. PubMed ID: 33030228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of intrabony periodontal defects using rhFGF-2 in combination with deproteinized bovine bone mineral or rhFGF-2 alone: A 6-month randomized controlled trial.
    Saito A; Bizenjima T; Takeuchi T; Suzuki E; Sato M; Yoshikawa K; Kitamura Y; Matsugami D; Aoki H; Kita D; Imamura K; Irokawa D; Seshima F; Tomita S
    J Clin Periodontol; 2019 Mar; 46(3):332-341. PubMed ID: 30758076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Chronic Periodontitis with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Wide Intrabony Defects:12-month Follow-up Case Series.
    Yoshida W; Takeuchi T; Imamura K; Seshima F; Saito A; Tomita S
    Bull Tokyo Dent Coll; 2020 Dec; 61(4):231-241. PubMed ID: 33177268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Case Report of Periodontal Regenerative Therapy Using Recombinant Human Fibroblast Growth Factor 2 and Deproteinized Bovine Bone Mineral with Non-incised Papillae Surgical Approach (NIPSA) for Angular Bone Defect in Patient with Stage III Grade C Periodontitis.
    Bizenjima T; Irokawa D; Yamada S; Saito A; Tomita S
    Bull Tokyo Dent Coll; 2023 Dec; 64(4):145-155. PubMed ID: 37967939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodontal Regenerative Therapy with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Patient with Chronic Periodontitis: An 18-month Follow-up Report.
    Bizenjima T; Irokawa D; Tanaka K; Saito A; Tomita S
    Bull Tokyo Dent Coll; 2021 Jun; 62(2):107-117. PubMed ID: 33994421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of periodontal wound healing/regeneration by recombinant human fibroblast growth factor-2 combined with β-tricalcium phosphate, carbonate apatite, or deproteinized bovine bone mineral in a canine one-wall intra-bony defect model.
    Shirakata Y; Setoguchi F; Sena K; Nakamura T; Imafuji T; Shinohara Y; Iwata M; Noguchi K
    J Clin Periodontol; 2022 Jun; 49(6):599-608. PubMed ID: 35322457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guided tissue regeneration combined with a deproteinized bovine bone mineral (Bio-Oss) in the treatment of intrabony periodontal defects: 6-year results from a randomized-controlled clinical trial.
    Stavropoulos A; Karring T
    J Clin Periodontol; 2010 Feb; 37(2):200-10. PubMed ID: 20653820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of rhFGF-2 in periodontal defect bone fill: A systematic review of the literature.
    Pouliou MM; Fragkioudakis I; Doufexi AE; Batas L
    J Periodontal Res; 2023 Aug; 58(4):733-744. PubMed ID: 37130815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
    Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
    J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome of periodontal regenerative therapy using collagen membrane and deproteinized bovine bone mineral: a 2.5-year follow-up study.
    Irokawa D; Takeuchi T; Noda K; Goto H; Egawa M; Tomita S; Sugito H; Nikaido M; Saito A
    BMC Res Notes; 2017 Feb; 10(1):102. PubMed ID: 28212665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of systemic antibiotics on the outcomes of regenerative periodontal surgery in intrabony defects: a randomized, controlled, clinical study.
    Pietruska M; Dolińska E; Milewski R; Sculean A
    Clin Oral Investig; 2021 May; 25(5):2959-2968. PubMed ID: 33048260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human fibroblast growth factor and autogenous bone for periodontal regeneration: Alone or in combination? A randomized clinical trial.
    Kojima K; Kamata Y; Shimizu T; Sato S; Suzuki S; Takanashi Y; Hojo S; Yoshino T; Fuchida S; Tamura T; Minabe M; Kodama T; Kessoku T; Oyamada S
    J Periodontal Res; 2024 Jun; ():. PubMed ID: 38853125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Outcomes of Periodontal Regenerative Therapy Using rhFGF-2 with a Modified Minimally Invasive Surgical Technique for Intrabony Defects: Case Series with a 12-Month Follow-up.
    Imamura K; Suzuki E; Takeuchi T; Saito A
    Int J Periodontics Restorative Dent; 2022; 42(4):507-513. PubMed ID: 35830316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Stage III Grade C Periodontitis with Periodontal Regenerative Therapy including Guided Tissue Regeneration (GTR) and Recombinant Human Fibroblast Growth Factor (rhFGF)-2: A Case Report.
    Iwaki J; Imamura K; Tanaka K; Sugito H; Saito A
    Bull Tokyo Dent Coll; 2023 Jan; 63(4):189-198. PubMed ID: 36384760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human intrabony defect regeneration with rhFGF-2 and hyaluronic acid - a randomized controlled clinical trial.
    de Santana RB; de Santana CM
    J Clin Periodontol; 2015 Jul; 42(7):658-65. PubMed ID: 25933201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guided tissue regeneration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: radiographic predictors and outcomes.
    Liñares A; Cortellini P; Lang NP; Suvan J; Tonetti MS;
    J Clin Periodontol; 2006 May; 33(5):351-8. PubMed ID: 16634957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
    Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
    J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of periodontal minimally invasive surgery with and without regenerative materials for treatment of intrabony defect: a randomized clinical trial.
    Liu B; Ouyang X; Kang J; Zhou S; Suo C; Xu L; Liu J; Liu W
    Clin Oral Investig; 2022 Feb; 26(2):1613-1623. PubMed ID: 34414521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of platelet-rich plasma in the treatment of periodontal intrabony defects in humans.
    Ouyang XY; Qiao J
    Chin Med J (Engl); 2006 Sep; 119(18):1511-21. PubMed ID: 16996004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.